Carbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation

Neuroreport. 2008 Oct 29;19(16):1601-4. doi: 10.1097/WNR.0b013e3283129790.

Abstract

The heme oxygenase (HO)-carbon monoxide pathway was earlier shown to increase hypothalamic blood flow after inhibition of nitric oxide synthesis in rats. We hypothesized that this effect is mediated by prostaglandin E2 (PGE2). Inhibition of constitutive HO activity decreased cerebral PGE2 production and simultaneously increased hypothalamic nitric oxide synthase (NOS) activity without changing hypothalamic blood flow. Furthermore, HO blockade induced cyclooxygenase-dependent decrease and NOS-mediated increase of the hypothalamic blood flow after inhibition of NOS and cyclooxygenase, respectively. Therefore, constitutive carbon monoxide release seems to have two indirect effects on the hypothalamic circulation: vasodilation mediated by PGE2 and vasoconstriction as a result of NOS inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / cerebrospinal fluid
  • 6-Ketoprostaglandin F1 alpha / metabolism
  • Animals
  • Blood Gas Analysis / methods
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Carbon Monoxide / metabolism*
  • Cyclooxygenase Inhibitors / administration & dosage
  • Cyclooxygenase Inhibitors / pharmacology
  • Deuteroporphyrins / administration & dosage
  • Deuteroporphyrins / pharmacology
  • Diclofenac / administration & dosage
  • Diclofenac / pharmacology
  • Dinoprost / cerebrospinal fluid
  • Dinoprost / metabolism
  • Dinoprostone / cerebrospinal fluid
  • Dinoprostone / metabolism*
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Heme Oxygenase (Decyclizing) / antagonists & inhibitors
  • Heme Oxygenase (Decyclizing) / metabolism*
  • Hypothalamus / blood supply*
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Injections, Intraperitoneal
  • Injections, Intravenous
  • Male
  • NG-Nitroarginine Methyl Ester / administration & dosage
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Prostaglandin D2 / cerebrospinal fluid
  • Prostaglandin D2 / metabolism
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Rats
  • Rats, Wistar

Substances

  • Cyclooxygenase Inhibitors
  • Deuteroporphyrins
  • Enzyme Inhibitors
  • zinc deuteroporphyrin IX 2,4-bis(glycol)
  • Diclofenac
  • 6-Ketoprostaglandin F1 alpha
  • Carbon Monoxide
  • Dinoprost
  • Heme Oxygenase (Decyclizing)
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone
  • Prostaglandin D2
  • NG-Nitroarginine Methyl Ester